Semaglutide

De Wikipedia, le encyclopedia libere
Semaglutide
instantia de: type of chemical entity[*]
subclasse de: synthetic peptide[*], glucagon-like peptide-1[*]


Commons: Semaglutide

Semaglutide (Ozempic, Wegovy, Rybelsus) es un medicamento antidabetic contra le diabete de typo 2 (ligate al obesitate).

Serea effictive contra le renal insufficientia chronic.[1]

Malversate uso[modificar | modificar fonte]

Le uso inappropriate del semaglutide pro su anorectic (appetito reprimente) proprietates in non-diabetic patientes es contraindicate: pote causar secundari effectos como gastrointestinal disordine, pancreatite o hypoglycemia.[2]

Referentias[modificar fonte]

  1. https://bwhealthcareworld.businessworld.in/article/Novo-Nordisk-To-Stop-Trial-Of-Ozempic-For-Kidney-Failure-Treatment/11-10-2023-494538/
  2. David Paitraud (2023-03-02). Usage détourné d'OZEMPIC (sémaglutide) : la France renforce la surveillance. Vidal.